Vault-13

Knoll Capital Management, LLC

MIAMI, FL · CIK 1325083 · 13F filing filed 2022-05-16

No investment adviser registration (Form ADV) found for this filer. It may be a parent company whose subsidiaries are the registered advisers, a bank or insurer, or a manager based outside the US.

$159.3m reported value -12.4% vs Q4 2021
41positions
87.3%in top 10
5 new 6 added 3 reduced 2 sold out vs Q4 2021

Holdings, Q1 2022

The small lines show how much was held over the last 4 quarters (adjusted for stock splits).

#SecurityTickerShares Value% of portfolioChangeShares change
1 BIOHAVEN PHARMACTL HLDG CO L COM BHVN BHVN 900,844 $106.8m67.04% 67.04% AddedShares held: Q2 2021 856.8k, Q3 2021 856.8k, Q4 2021 896.8k, Q1 2022 900.8k +4.0k +4,000 0.5%
2 ENTERA BIO LTD SHS ENTX ENTX 2,484,275 $7.1m4.47% 4.47% UnchangedShares held: Q2 2021 2.5m, Q3 2021 2.5m, Q4 2021 2.5m, Q1 2022 2.5m
3 EIGER BIOPHARMACEUTICALS INC COM CLDN CLDN 694,232 $5.8m3.62% 3.62% UnchangedShares held: Q2 2021 694.2k, Q3 2021 694.2k, Q4 2021 694.2k, Q1 2022 694.2k
4 Orgenesis, Inc. COM COM 1,316,364 $4.6m2.87% 2.87% UnchangedShares held: Q2 2021 1.3m, Q3 2021 1.3m, Q4 2021 1.3m, Q1 2022 1.3m
5 ALDEYRA THERAPEUTICS INC COM ALDX ALDX 759,405 $3.4m2.12% 2.12% UnchangedShares held: Q2 2021 569.4k, Q3 2021 569.4k, Q4 2021 759.4k, Q1 2022 759.4k
6 CORBUS PHARMACEUTICALS HLDGS COM CRBP CRBP 5,045,870 $2.7m1.68% 1.68% UnchangedShares held: Q2 2021 5.0m, Q3 2021 5.0m, Q4 2021 5.0m, Q1 2022 5.0m
7 ANAVEX LIFE SCIENCES CORP COM NEW AVXL AVXL 210,789 $2.6m1.63% 1.63% NewShares held: Q2 2021 0, Q3 2021 0, Q4 2021 0, Q1 2022 210.8k
8 APPLIED THERAPEUTICS INC COM APLT APLT 1,082,123 $2.3m1.43% 1.43% AddedShares held: Q2 2021 1.0m, Q3 2021 1.0m, Q4 2021 1.0m, Q1 2022 1.1m +50.0k +50,000 4.8%
9 BLACKSTONE GROUP L P COM UNIT LTD BX BX 16,000 $2.0m1.26% 1.26% ReducedShares held: Q2 2021 30.0k, Q3 2021 24.0k, Q4 2021 24.0k, Q1 2022 16.0k -8.0k -8,000 -33.3%
10 ARISTA NETWORKS INC COM COM 13,800 $1.9m1.20% 1.20% UnchangedShares held: Q2 2021 13.8k, Q3 2021 13.8k, Q4 2021 13.8k, Q1 2022 13.8k
11 CVS HEALTH CORP COM CVS CVS 14,500 $1.5m0.92% 0.92% UnchangedShares held: Q2 2021 14.5k, Q3 2021 14.5k, Q4 2021 14.5k, Q1 2022 14.5k
12 THERMO FISHER SCIENTIFIC INC COM TMO TMO 2,100 $1.2m0.78% 0.78% UnchangedShares held: Q2 2021 2.1k, Q3 2021 2.1k, Q4 2021 2.1k, Q1 2022 2.1k
13 ALTRIA GROUP INC COM MO MO 22,700 $1.2m0.74% 0.74% UnchangedShares held: Q2 2021 22.7k, Q3 2021 22.7k, Q4 2021 22.7k, Q1 2022 22.7k
14 BOOZ ALLEN HAMILTON HLDG COR CL A BAH BAH 13,000 $1.1m0.72% 0.72% UnchangedShares held: Q2 2021 13.0k, Q3 2021 13.0k, Q4 2021 13.0k, Q1 2022 13.0k
15 CENTURYLINK INC COM CTL CTL 100,000 $1.1m0.71% 0.71% UnchangedShares held: Q2 2021 220.0k, Q3 2021 100.0k, Q4 2021 100.0k, Q1 2022 100.0k
16 VISA INC COM CL A V V 4,850 $1.1m0.67% 0.67% UnchangedShares held: Q2 2021 4.8k, Q3 2021 4.8k, Q4 2021 4.8k, Q1 2022 4.8k
17 CORNING INC COM GLW GLW 26,600 $982.0k0.62% 0.62% UnchangedShares held: Q2 2021 26.6k, Q3 2021 26.6k, Q4 2021 26.6k, Q1 2022 26.6k
18 AGNICO EAGLE MINES LTD COM AEM AEM 15,393 $943.0k0.59% 0.59% AddedShares held: Q2 2021 6.9k, Q3 2021 6.9k, Q4 2021 6.9k, Q1 2022 15.4k +8.5k +8,493 123.1%
19 ADVANCED MICRO DEVICES INC COM AMD AMD 8,200 $897.0k0.56% 0.56% ReducedShares held: Q2 2021 12.3k, Q3 2021 12.3k, Q4 2021 12.3k, Q1 2022 8.2k -4.2k -4,150 -33.6%
20 ASML HOLDING N V N Y REGISTRY SHS ASML ASML 1,280 $855.0k0.54% 0.54% UnchangedShares held: Q2 2021 0, Q3 2021 1.3k, Q4 2021 1.3k, Q1 2022 1.3k
21 OSHKOSH CORP COM OSK OSK 8,450 $850.0k0.53% 0.53% UnchangedShares held: Q2 2021 0, Q3 2021 0, Q4 2021 8.4k, Q1 2022 8.4k
22 ALTIMMUNE INC COM NEW ALT ALT 132,978 $810.0k0.51% 0.51% UnchangedShares held: Q2 2021 50.0k, Q3 2021 133.0k, Q4 2021 133.0k, Q1 2022 133.0k
23 ABEONA THERAPEUTICS INC COM COM 2,215,740 $709.0k0.44% 0.44% UnchangedShares held: Q2 2021 2.9m, Q3 2021 2.9m, Q4 2021 2.2m, Q1 2022 2.2m
24 OSISKO GOLD ROYALTIES LTD COM COM 190,000 $612.0k0.38% 0.38% UnchangedShares held: Q2 2021 190.0k, Q3 2021 190.0k, Q4 2021 190.0k, Q1 2022 190.0k
25 SPERO THERAPEUTICS INC COM SPRO SPRO 70,000 $609.0k0.38% 0.38% NewShares held: Q2 2021 0, Q3 2021 0, Q4 2021 0, Q1 2022 70.0k
26 FRANCO NEV CORP COM FNV FNV 3,750 $598.0k0.38% 0.38% UnchangedShares held: Q2 2021 3.8k, Q3 2021 3.8k, Q4 2021 3.8k, Q1 2022 3.8k
27 SEABRIDGE GOLD INC COM COM 32,000 $592.0k0.37% 0.37% UnchangedShares held: Q2 2021 32.0k, Q3 2021 32.0k, Q4 2021 32.0k, Q1 2022 32.0k
28 MAVERIX METALS INC COM NEW COM NEW 115,000 $552.0k0.35% 0.35% UnchangedShares held: Q2 2021 115.0k, Q3 2021 115.0k, Q4 2021 115.0k, Q1 2022 115.0k
29 PAN AMERN SILVER CORP COM PAAS PAAS 16,300 $445.0k0.28% 0.28% AddedShares held: Q2 2021 8.2k, Q3 2021 8.2k, Q4 2021 8.2k, Q1 2022 16.3k +8.1k +8,100 98.8%
30 FIRST MAJESTIC SILVER CORP COM AG AG 33,000 $434.0k0.27% 0.27% UnchangedShares held: Q2 2021 0, Q3 2021 0, Q4 2021 33.0k, Q1 2022 33.0k
31 SILVERCREST METALS INC COM SIL SIL 48,000 $428.0k0.27% 0.27% AddedShares held: Q2 2021 42.0k, Q3 2021 42.0k, Q4 2021 42.0k, Q1 2022 48.0k +6.0k +6,000 14.3%
32 BIOXCEL THERAPEUTICS INC COM COM 20,000 $418.0k0.26% 0.26% UnchangedShares held: Q2 2021 20.0k, Q3 2021 20.0k, Q4 2021 20.0k, Q1 2022 20.0k
33 MIRATI THERAPEUTICS INC COM MRTX MRTX 5,000 $411.0k0.26% 0.26% NewShares held: Q2 2021 0, Q3 2021 0, Q4 2021 0, Q1 2022 5.0k
34 EQUINOX GOLD CORP COM EQX EQX 45,500 $376.0k0.24% 0.24% UnchangedShares held: Q2 2021 45.5k, Q3 2021 45.5k, Q4 2021 45.5k, Q1 2022 45.5k
35 MAG SILVER CORP COM MAG MAG 21,750 $352.0k0.22% 0.22% AddedShares held: Q2 2021 17.3k, Q3 2021 17.3k, Q4 2021 17.3k, Q1 2022 21.8k +4.5k +4,450 25.7%
36 CONTEXT THERAPEUTICS INC COM CNTX CNTX 139,520 $303.0k0.19% 0.19% NewShares held: Q2 2021 0, Q3 2021 0, Q4 2021 0, Q1 2022 139.5k
37 SOLIGENIX INC COM COM 271,580 $198.0k0.12% 0.12% ReducedShares held: Q2 2021 787.8k, Q3 2021 787.8k, Q4 2021 436.6k, Q1 2022 271.6k -165.0k -165,000 -37.8%
38 ANNOVIS BIO INC COM ANVS ANVS 14,210 $190.0k0.12% 0.12% UnchangedShares held: Q2 2021 39.2k, Q3 2021 14.2k, Q4 2021 14.2k, Q1 2022 14.2k
39 ORAMED PHARMACEUTICALS INC COM NEW ORMP ORMP 20,000 $173.0k0.11% 0.11% NewShares held: Q2 2021 0, Q3 2021 0, Q4 2021 0, Q1 2022 20.0k
40 ANGION BIOMEDICA CORP COM COM 60,000 $127.0k0.08% 0.08% UnchangedShares held: Q2 2021 60.0k, Q3 2021 60.0k, Q4 2021 60.0k, Q1 2022 60.0k
41 APPLIED GENETIC TECHNOLOGIES COM AGTC AGTC 100,000 $107.0k0.07% 0.07% UnchangedShares held: Q2 2021 100.0k, Q3 2021 100.0k, Q4 2021 100.0k, Q1 2022 100.0k

Sold out since Q4 2021

SecurityTickerShares held beforeValue then
Anavex Life Sciemves Corp 210,789 $3.7m210.8k shares
KIRKLAND LAKE GOLD LTD KL KL 10,750 $451.0k10.8k shares

Stakes above 5%

Companies where this manager has reported owning more than 5% of a class of shares, on Schedule 13D (may seek influence) or 13G (passive): its latest filing for each, from 19 Dec 2024 on.

CompanyTickerStakeChange ScheduleLast filed
ELICIO THERAPEUTICS INC ELTX · 13G · filed 2026-07-08 ELTX 5.3%≈ $4.7m +0.1 pts 13G 2026-07-08